遠大控股(000626.SZ):終止收購遼寧微科100%股權
格隆匯8月18日丨遠大控股(000626.SZ)公佈,此前披露,2021年4月26日,公司召開第九屆董事會2021年度第四次會議,審議通過了關於《收購遼寧微科生物工程股份有限公司100%股權》的議案,並與郭春麗等19位轉讓方簽署《遼寧微科生物工程股份有限公司股權轉讓協議》。股權轉讓協議約定,公司將對遼寧微科生物工程股份有限公司(以下簡稱:遼寧微科)開展進一步盡職調查,並根據盡職調查結果作進一步研判,決定最終是否實施收購遼寧微科股權。
股權轉讓協議簽署後,公司對遼寧微科全面開展盡職調查工作。根據盡職調查結果,公司認為轉讓方和遼寧微科在現階段無法滿足股權轉讓協議所約定的收購先決條件等條款,因此決定終止本次收購。
終止收購遼寧微科100%股權不會對公司的生產經營及財務狀況造成較大影響,也不會影響公司未來的發展戰略。公司將以生態農業作為公司重點發展的產業領域之一,繼續深化產業轉型。
因為收購遼寧微科100%股權是公司2021 年非公開發行A 股股票的募集資金投資項目之一,公司將對2021年非公開發行A股股票的預案等文件進行相應的修改並按照規定履行審批程序和信息披露義務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.